Literature DB >> 17130423

Severe botulism after focal injection of botulinum toxin.

N Souayah1, H Karim, S S Kamin, J McArdle, S Marcus.   

Abstract

We report a 34-year-old woman who developed clinical botulism after the cosmetic use of an unapproved botulinum toxin type A. Electrophysiologic findings demonstrated complete denervation with complete electrical silence. She had a lengthy recovery but was able to ambulate by discharge.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17130423     DOI： 10.1212/01.wnl.0000244417.34846.b6

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  8 in total

1.  "Saving Face": An Online Study of the Injecting Use of DIY Botox and Dermal Filler Kits.

Authors:  Rebekah Brennan; John S G Wells; Marieclaire Van Hout
Journal:  Plast Surg (Oakv)       Date:  2018-04-19       Impact factor: 0.947

2.  Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.

Authors:  Baskaran Thyagarajan; Joseph G Potian; Carmen C Garcia; Kormakur Hognason; Katerina Capková; Scott T Moe; Alan R Jacobson; Kim D Janda; Joseph J McArdle
Journal:  Neuropharmacology       Date:  2010-03-06       Impact factor: 5.250

3.  Noncosmetic periocular therapeutic applications of botulinum toxin.

Authors:  Pelin Kaynak-Hekimhan
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

4.  Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a.

Authors:  Baskaran Thyagarajan; Natalia Krivitskaya; Joseph G Potian; Kormakur Hognason; Carmen C Garcia; Joseph J McArdle
Journal:  J Pharmacol Exp Ther       Date:  2009-08-04       Impact factor: 4.030

5.  Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.

Authors:  Padmamalini Baskaran; Teresa E Lehmann; Elena Topchiy; Nagarajan Thirunavukkarasu; Shuowei Cai; Bal Ram Singh; Sharad Deshpande; Baskaran Thyagarajan
Journal:  Toxicon       Date:  2013-06-25       Impact factor: 3.033

6.  Tyrosine phosphorylation of botulinum neurotoxin protease domains.

Authors:  Stephen Toth; Ernst E Brueggmann; George A Oyler; Leonard A Smith; Harry B Hines; S Ashraf Ahmed
Journal:  Front Pharmacol       Date:  2012-06-04       Impact factor: 5.810

7.  Takotsubo-like Myocardial Dysfunction in a Patient with Botulism.

Authors:  Shuichi Tonomura; Yoshiaki Kakehi; Masatoshi Sato; Yuki Naito; Hisao Shimizu; Yasunobu Goto; Nobuyuki Takahashi
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

Review 8.  Therapeutic use of immunoglobulins.

Authors:  E Richard Stiehm; Jordan S Orange; Mark Ballow; Heather Lehman
Journal:  Adv Pediatr       Date:  2010
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.